Fecal microbiota transplantation
Fecal microbiota transplantation is a medical procedure with 130 clinical trials. Currently 35 active trials ongoing. Historical success rate of 73.5%.
Success Metrics
Based on 25 completed trials
Phase Distribution
Phase Distribution
36
Early Stage
25
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
61.0%
25 of 41 finished
39.0%
16 ended early
35
trials recruiting
130
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Clinical Trials (130)
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Neurocognitive Effects of FMT in MDD Patients With and Without IBS
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease
PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy
Evaluation of the Outcome of Fecal Microbiota Transplantation
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
Fecal Microbiota Transplantation in aGvHD After ASCT
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation
Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 130